Establish a new culture for learning in Gastroenterology 2020 Conference

Top Quote Allied Academies hosts the 5th International Conference on Gastroenterology and Hepatology (Gastroenterology 2020) that discusses the new paradigm approach to probe every single element in Gastroenterology and Hepatology. End Quote
  • (1888PressRelease) November 07, 2019 - Gastroenterology 2020 will be organized around the theme “Recent Advancements in Gastroenterology & Hepatology” on March 19-20, 2020 at Kuala Lumpur, Malaysia.

    The conference provides an opportunity for all the stakeholders to gather all the Researchers, principal investigators, experts and researchers working under academia and healthcare industry, Business Delegates, Scientists and students all across the globe to provide an international forum for the dissemination of original research results, new ideas and practical development experiences.

    The main focus on the Conference includes about new mechanism for targeting digestive system and its disorders, Latest uses of Clinical Gastroenterology, Imaging in Gastroenterology, Molecular Screening for Hepatitis Virus, Functional GI and Motility Disorders, Therapeutic and Diagnostic Gastroenterology and many more.

    Why & whom to attend?
    The attendees of the Conference will enjoy the special events which include new mechanisms on various organs from mouth to anus, along the alimentary canal. Experts working and practicing in the particular field are recognized as gastroenterologists. These eminent members complete their degrees focusing on Supplement Induced Liver Injury, intestinal functioning, enzyme secretion, Medical Therapies for IBS, advanced endoscopy, inflammatory bowel disease (IBD), motility and other popular subjects. It is a perfect platform for Gastroenterologists, Hepatologists, Pediatrition, Research Scholars, industrial professionals and student delegates from healthcare sectors to explore every single element in Gastroenterology and Hepatology.

    Gastroenterology 2020 provide an international platform for young researchers, students and practitioners to meet the eminent presenters and delegates including clinicians, researchers, surgeons, gastroenterologist, hepatologists, endoscopy experts, health care practitioners, treatment providers as well as industrial leaders from all across the globe. For sharing the recent advancements of the related stream, Gastroenterology conferences are being organized in USA, Europe, Middle East, Asia Pacific and Australian countries.

    All the papers to be presented in Gastroenterology 2020 will be published in Allied Journal
    • Journal of Archives of Digestive Disorders
    • Journal of Hepatology and Gastrointestinal Disorders and
    • Journal of Clinical and Molecular pathology in regard to this topic.

    Conference Highlights:
    • Clinical Gastroenterology
    • Therapeutic and Diagnostic Gastroenterology
    • Imaging in Gastroenterology
    • Surgical, Endoscopic, and Future Therapies
    • Hepatology and Nutrition
    • Pediatric Gastroenterology
    • Medical Therapies for IBS
    • Gastroenterology & Pregnancy

    Media Partners:
    • King Congress
    • PlacidWay

    The rise in the instances of Crohn’s disease, inflammatory bowel disease, ulcerative colitis, and such other diseases is also expected to create a rise in demand for the gastrointestinal diseases market. The growth in the demand and sale for the gastrointestinal drugs across the developing and developed markets is also attributed to be one of the major driving factors for this market.

    • In the United States, 20 per cent to 30 percent of individuals living with HIV is coinfected with HCV. Hepatitis C is common among individuals living with HIV. This implies that approximately 225,000 to 330,000 individuals in the United States are living with both viruses.

    • The prescription therapies market is expected to grow from $18.6 billion in 2016 to nearly $22.1 billion in 2021 at a CAGR of 3.5% for the period 2016-2021 and the diagnostics market over the next five years will grow from $17.7 billion in 2016 to $23.5 billion in 2021 at a CAGR of 5.9% for the period 2016-2021.

    • According to Market research the Global Gastrointestinal Drugs Market Revenue by Region in 2016, North America was the highest by getting the revenue of 17,288 US Dollar Million, while the Middle East and Africa Continent was having least generation of revenue. But, the Future scope is much brighter in Coming years in Middle East countries.

    • The demand for ambulatory surgery center is high in Europe and the Asia Pacific owing to the government initiatives to overcome the shortage of medical facilities in remote areas of developing countries such as India and China.

    • This study analyses various therapeutic options currently on the market as well as potential products and classes of products that are likely to have a significant impact on the future for the prescription as well as the over-the-counter (OTC) gastrointestinal drug markets. The gastrointestinal market is one of the key therapeutic areas most significantly affected by the generic erosion of blockbusters.

  • FB Icon Twitter Icon In-Icon
Contact Information